Musculoskeletal Pain Report – Global API Manufacturers, Sales Figures, Marketed and Phase III Drugs Landscape, 2017-2018 – Research and Markets

12-May-2017 Intellasia | BusinessWire | 8:55 PM Print This Post

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Musculoskeletal
Pain – Global API Manufacturers, Marketed and Phase III Drugs Landscape,
drug pipelines to their offering.

Musculoskeletal Pain – Global API Manufacturers, Marketed and Phase III
Drugs Landscape, 2017, provides comprehensive insights about the
marketed drugs, drug sales, Phase III pipeline drugs and their API
Manufacturers across the globe.

A key objective of the Musculoskeletal Pain Report is to understand the
market and pipeline status of the drugs around the Musculoskeletal Pain
to explore the generic development opportunities, licensing
opportunities and to gain competitive advantage on designing pipeline
strategies. The Report provides the historical and forecasted sales of
the drugs till 2018.

The Musculoskeletal Pain Report gives insights into patents providing
the patent protection data and marketing exclusivity of all the drugs
across the Musculoskeletal Pain.

While the leading brands, companies and chemicals are considered
thoroughly, the report also provides details on the Global API
Manufacturers across the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Musculoskeletal Pain

7. Phase III Drugs for Musculoskeletal Pain

8. Discontinued Drugs for Musculoskeletal Pain

9. Appendix

For more information about this drug pipelines report visit


Research and Markets
Laura Wood, Senior Manager
[email protected]
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Topics: Analgesics,
Disorders Drugs


Category: BusinessWire, PRAsia

Print This Post

Comments are closed.